936 Tolerability, Adherence and Completion of New Occupational HIV Post-Exposure Prophylaxis Regimens (Tenofovir + Emtricitabine and Raltegravir)

Por Bock, Izona, Felsen, Uriel, Catalano, Michela, Hacker, Susan, Zingman, Barry
Publicado no Open Forum Infect Dis (2014)

Brucella Exposure Risk Events in 10 Clinical Laboratories, New York City, USA, 2015 to 2017

Por Ackelsberg, Joel, Liddicoat, Anna, Burke, Taryn, Szymczak, Wendy A., Levi, Michael H., Ostrowsky, Belinda, Hamula, Camille, Patel, Gopi, Kopetz, Virginia, Saverimuttu, Jessie, Sordillo, Emilia Mia, D’Souza, David, Mitchell, Elizabeth A., Lowe, William, Khare, Reeti, Tang, Yi-Wei, Bianchi, Anabella Lucca, Egan, Christina, Perry, Michael J., Hughes, Scott, Rakeman, Jennifer L., Adams, Eleanor, Kharod, Grishma A., Tiller, Rebekah, Saile, Elke, Lee, Stephen, Gonzalez, Edimarlyn, Hoppe, Brett, Leviton, Ira M., Hacker, Susan, Ni, Kuey Fen, Orsini, Reina L., Jhaveri, Sangam, Mazariegos, Irving, Dingle, Tanis, Koll, Brian, Stoddard, Robyn A., Galloway, Renee, Hoffmaster, Alex, Fine, Annie, Lee, Ellen, Dentinger, Catherine, Harrison, Emily, Layton, Marcelle
Publicado no J Clin Microbiol (2020)